A method for synthesizing 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol and its intermediates

By simplifying the synthesis route and reducing the use of precious metals, the problems of high cost, complicated steps, and low overall yield in the synthesis of 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol have been solved, enabling low-cost, high-yield industrial production.

CN123062401APending Publication Date: 2026-11-10SUZHOU CHUKAI PHARMA TECH CO LTD
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202611513777.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-28
Publication Date
2026-11-10

AI Technical Summary

Technical Problem

The existing technology for synthesizing 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol has high cost, complicated steps, and low overall yield, making it difficult to meet the needs of industrial production.

Method used

Compound IV was reacted with an iodine reagent to give compound V; compound V was reacted with a copper catalyst and a trifluoromethylating agent to give compound VI; compound VI was reacted with a palladium catalyst and a borizing agent to give compound VII; compound VII was reacted with an oxidizing agent and an acidic auxiliary agent to give compound I, which simplifies the synthetic route and reduces the use of precious metals.

Benefits of technology

The synthesis of 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol with low cost and high overall yield was achieved, which is suitable for large-scale industrial production with an overall yield of 52.2% to 58.2%.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123062401A_ABST
    Figure CN123062401A_ABST
Patent Text Reader

Abstract

This invention discloses a method for synthesizing 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol and its intermediates. The synthesis of 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol includes the following steps: reacting compound IV with an iodine reagent to obtain compound V; reacting compound V under a copper catalyst and a trifluoromethylating agent to obtain compound VI; reacting compound VI under a palladium catalyst and a borizing agent to obtain compound VII; and reacting compound VII under an oxidizing agent and an acidic auxiliary agent to obtain 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol. This invention eliminates the hydroxyl protection and deprotection steps of existing technologies, improving atom utilization and overall yield, with an overall yield of up to 58.2%. The entire reaction is carried out at atmospheric pressure, eliminating the need for high-pressure hydrogenation equipment. It requires less precious metal, has low production costs, uses readily available raw materials, and is safe to operate, making it suitable for industrial production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of pharmaceutical intermediate synthesis technology, specifically relating to the synthesis method of 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol and its intermediates. Background Technology

[0002] 4-Methyl-2-(trifluoromethyl)pyrimidin-5-ol is an important pharmaceutical intermediate with significant applications in the treatment of bronchoconstriction, inflammation, respiratory tract inflammation, and vasoconstriction.

[0003] Patent WO2023005894 discloses a synthetic route for 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol. This route uses methyl benzyloxyacetate as the starting material, undergoing Claisen condensation and cyclization with trifluoroacetamidine to construct a pyrimidin ring. The pyrimidin ring is then introduced via chlorination, palladium-catalyzed Suzuki coupling to introduce a methyl group, and hydrogenation on palladium carbon to debenzylate, yielding 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol. This process has significant drawbacks: firstly, the cyclization starting material, trifluoroacetamidine, is expensive, and the methylation requires palladium acetate catalysis, resulting in high material costs; secondly, the route employs a benzyloxy group protection strategy, adding two additional protection and deprotection steps, making the synthesis lengthy. These multiple conversions lead to material losses, resulting in a low overall yield of approximately 16%, which is unsuitable for industrial-scale production.

[0004]

[0005] Therefore, developing a low-cost, simple, and large-scale industrial production method for 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol has significant practical value. Summary of the Invention

[0006] Purpose of the invention: In order to overcome the technical problems of high cost, complicated steps, low overall yield and difficulty in industrialization of the prior art, the present invention discloses a low-cost, high-yield, safe and easy-to-scale synthesis method of 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol.

[0007] This invention discloses a method for synthesizing 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol, comprising the following steps: reacting compound IV with an iodine reagent to obtain compound V; reacting compound V under copper catalyst and trifluoromethylating agent conditions to obtain compound VI; reacting compound VI under palladium catalyst and borizing agent conditions to obtain compound VII; reacting compound VII under oxidizing agent and acidic auxiliary conditions to obtain compound I; the synthetic route is as follows: .

[0008] This invention also discloses a method for synthesizing 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol, comprising the following steps: reacting compound II under the conditions of an iron catalyst, a methyl Grignard reagent, and an amide co-solvent to obtain compound III; reacting compound III with a brominating reagent to obtain compound IV; the synthetic route is as follows: .

[0009] Furthermore, in the step of synthesizing compound III from compound II, the iron catalyst is ferric chloride, ferrous chloride, ferric bromide, ferrous bromide, or ferric acetylacetone; the methyl Grignard reagent is methyl magnesium chloride or methyl magnesium bromide; and the reaction solvent is tetrahydrofuran or 2-methyltetrahydrofuran.

[0010] Furthermore, in the step of synthesizing compound III from compound II, the amide co-solvent is any one of N-methylpyrrolidone, N-ethylpyrrolidone, N,N-dimethylformamide, and N,N-dimethylpropenylurea; the molar ratio of compound II: amide co-solvent: iron catalyst: methyl Grignard reagent is 1:1~2:0.01~0.05:1~3; and the reaction temperature is -60~-55℃.

[0011] Furthermore, in the step of synthesizing compound IV from compound III, the brominating agent is any one of N-bromosuccinimide, dibromohydantoin, or liquid bromine; the reaction solvent is any one of tetrahydrofuran, 2-methyltetrahydrofuran, acetonitrile, methanol, dichloromethane, or chloroform.

[0012] Furthermore, in the step of synthesizing compound V from compound IV, the iodochemical reagent is hydroiodic acid.

[0013] Further, in the step of synthesizing compound VI from compound V, the copper catalyst is any one of cuprous iodide, cuprous bromide, and cuprous chloride; the trifluoromethylating agent is any one of methyl 2,2-difluoro-2-(fluorosulfonyl)acetate, trifluoromethyltrimethylsilane, and sodium trifluoromethanesulfonate; the molar ratio of compound V:copper catalyst:trifluoromethylating agent is 1:0.05~0.2:1~1.5; and the reaction temperature is 90~100℃.

[0014] Furthermore, in the step of synthesizing compound VII from compound VI, the palladium catalyst is bis(triphenylphosphine)palladium dichloride or tetra(triphenylphosphine)palladium; the borate is pinacol diborate; the base is potassium acetate; and the molar ratio of compound VI:palladium catalyst:borate:base is 1:0.02~0.1:1~3:1.5~3.

[0015] Furthermore, in the step of synthesizing compound I from compound VII, the oxidant is hydrogen peroxide; and the acidic auxiliary is acetic acid.

[0016] The present invention also discloses a 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol intermediate having the structure shown in Formula VII: .

[0017] The beneficial effects of this invention are: This invention involves reacting compound IV with an iodine reagent to obtain compound V; reacting compound V with a copper catalyst and a trifluoromethylating agent to obtain compound VI; reacting compound VI with a palladium catalyst and a borizing agent to obtain compound VII, which is a new intermediate compound; and reacting compound VII with an oxidizing agent and an acidic auxiliary agent to obtain 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol. This invention eliminates the hydroxyl protection and deprotection operations of existing technologies, shortens the synthetic chain, and achieves a yield of up to 58.2%.

[0018] In this invention, compound II is used as the starting material and reacts with an inexpensive iron catalyst to obtain compound III. Compound III reacts with a brominating reagent to obtain compound IV. Compound IV then follows the above pathway to obtain compound I. The overall reaction yield can reach 52.2%. Copper catalyst is inexpensive and palladium catalyst has a low loading, which greatly reduces material costs and reduces the consumption of precious metals. There is no high-pressure hydrogenation throughout the process, and all six steps of the reaction are completed under normal pressure and mild conditions. It is simple, safe, and the raw materials are inexpensive and readily available, making it suitable for large-scale industrial production. Attached Figure Description

[0019] Figure 1 The 1H NMR spectrum of 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol is shown. Detailed Implementation

[0020] The present invention will be further described below with reference to specific embodiments, but these embodiments are merely exemplary and do not constitute any limitation on the scope of the present invention. Those skilled in the art should understand that modifications or substitutions can be made to the details and form of the technical solutions of the present invention without departing from the spirit and scope of the invention, but all such modifications and substitutions fall within the protection scope of the present invention.

[0021] Unless otherwise specified, the experimental methods described in the following examples are conventional methods; the reagents and materials described are commercially available unless otherwise specified.

[0022] Example 1 Synthesis of Compound III:

[0023] Under nitrogen protection, anhydrous THF (500 mL), 2,4-dichloropyrimidine (compound II, 50 g, 335.62 mmol), NMP (39.9 g, 402.74 mmol), and ferric chloride (1.09 g, 6.71 mmol) were added to a dry reaction flask. The mixture was stirred at room temperature until the solids were completely dissolved. The reaction system was then cooled to -60 to -55 °C and stirred for 30 min. While maintaining the temperature at -60 to -55 °C, methylmagnesium chloride Grignard reagent (3 M) was slowly added dropwise. THF solution (129 mL, 388 mmol) was added dropwise and stirred for 20 min under incubation. After the 2,4-dichloropyrimidine was completely consumed by TLC monitoring, the reaction was stopped, and the reaction was quenched by slowly adding 200 mL of ice water at 0-5 °C. The mixture was concentrated under reduced pressure to remove THF. The aqueous phase was extracted three times with MBTE (200 mL × 3). The organic phases were combined and washed with saturated brine (200 mL). The organic layer was separated and concentrated under reduced pressure. The concentrate was then cooled to -40 to -45 °C and stirred to crystallize for 1 h. The solid was collected by filtration and dried under vacuum to obtain compound III (39.95 g, yield 92.6%, purity 99.3%).

[0024] Example 2 Synthesis of compound IV:

[0025] Under nitrogen protection, compound III (30 g, 233.35 mmol) was dissolved in THF (500 mL), and NBS (49.84 g, 280.02 mmol) was added in small portions. The mixture was stirred at room temperature for 3 h. After compound III was completely consumed by TLC, the reaction was stopped. The reaction solution was concentrated under reduced pressure to remove the solvent. The residue was dissolved in ethyl acetate (300 mL), washed three times with saturated sodium carbonate aqueous solution (300 mL × 3), dried over anhydrous sodium sulfate, filtered, and evaporated to dryness to obtain compound IV (46.96 g, 97% yield). This compound did not require further purification and was directly added to the next reaction step.

[0026] Example 3 Synthesis of compound V:

[0027] Compound IV (40 g, 192.81 mmol) was dissolved in DCM (500 mL) at room temperature, and 57% hydroiodic acid aqueous solution (173 g, 771.24 mmol) was added dropwise. After the addition was complete, the mixture was stirred at room temperature for 12 h. After TLC monitoring showed that compound IV was completely consumed, the reaction solution was quenched with ice water and extracted twice with ethyl acetate (300 mL × 2). The organic phases were combined and washed successively with water (300 mL) and saturated brine (300 mL). The mixture was dried over anhydrous sodium sulfate, filtered, concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (eluent: petroleum ether / ethyl acetate = 5:1). The target fraction was collected and concentrated to give compound V (49.05 g, yield 85.1%, purity 99.2%).

[0028] Example 4 Synthesis of compound VI:

[0029] Compound V (40 g, 133.82 mmol), cuprous iodide (2.55 g, 13.38 mmol), and DMF (400 mL) were added to a dry reaction flask. Methyl 2,2-difluoro-2-(fluorosulfonyl)acetate (33.42 g, 173.97 mmol) was added dropwise. The mixture was heated to 100 °C with stirring and maintained at this temperature for 1 h. After complete consumption of compound V as monitored by TLC, the reaction was stopped. The reaction mixture was cooled to room temperature, and ethyl acetate (300 mL) and water (3...) were added. Extraction was performed by separation of the aqueous phase with ethyl acetate (300 mL). After standing and separation of the layers, the organic phase was separated. The aqueous phase was extracted once again with ethyl acetate (300 mL). All organic layers were combined and washed successively with saturated sodium bicarbonate aqueous solution (300 mL) and saturated saline solution (300 mL). The mixture was dried over anhydrous sodium sulfate, filtered, concentrated under reduced pressure, and the residue was purified by silica gel column chromatography using a gradient elution from dichloromethane to diethyl ether. The target component was collected and concentrated to give compound VI (27.96 g, yield 86.7%, purity 98.3%).

[0030] Example 5 Synthesis of compound VII:

[0031] Compound VI (25 g, 103.73 mmol), pinacol diborate (39.51 g, 155.60 mmol), PdCl2(PPh3)2 (3.64 g, 5.185 mmol), potassium acetate (20.36 g, 207.46 mol), and 1,4-dioxane (250 mL) were added to a dry reaction flask. The mixture was completely purged with nitrogen to remove oxygen, and the mixture was heated to 100 °C with stirring for 8 h. Compound VI was monitored by TLC. After complete consumption, the reaction was stopped, the reaction solution was cooled to room temperature, quenched with water (50 mL), and the aqueous phase was extracted twice with ethyl acetate (200 mL × 2). All organic phases were combined, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to remove the solvent. The crude product was purified by silica gel column chromatography (eluting with a gradient of n-hexane / ethyl acetate, 0–25% ethyl acetate). The target fraction was collected and concentrated to give compound VII (25.49 g, yield 85.3%, purity 98.9%). LCMS (ESI) m / z: 289.13, [M + H] + ).

[0032] Example 6 Synthesis of Compound I:

[0033] Compound VII (20 g, 69.43 mmol), acetic acid (100 mL), and THF (200 mL) were added to a dry reaction flask, followed by the addition of 30% hydrogen peroxide solution (15.74 g, 138.85 mmol). The mixture was stirred at room temperature for 3 h. After compound VII was completely consumed by TLC monitoring, the reaction was stopped, and the reaction was quenched by adding saturated sodium thiosulfate aqueous solution (100 mL). The aqueous phase was extracted three times with ethyl acetate (100 mL × 2). All organic phases were combined, washed with saturated sodium thiosulfate aqueous solution (100 mL), dried over anhydrous sodium sulfate, filtered, concentrated under reduced pressure to remove the solvent, and the crude product was purified by silica gel column chromatography (eluent: n-hexane / ethyl acetate, ethyl acetate gradient elution of 10-50%). The crude product was dried to give 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol (compound I, 11.43 g, yield 92.4%, purity 99.6%). The 1H NMR spectrum of 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol is shown below. Figure 1 As shown, 1 H NMR (400MHz, DMSO-d6) δ: 11.31(s, 1H), 8.35(s, 1H), 2.48(s, 3H).

[0034] The above specific embodiments further illustrate the purpose, technical solution and beneficial effects of this application. It should be understood that the above are only specific embodiments of this application and are not intended to limit the scope of protection of this application. Any modifications, equivalent substitutions, improvements, etc., made on the basis of the technical solution of this application should be included within the scope of protection of this application.

Claims

1. A method for synthesizing 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol, characterized in that, The reaction includes the following steps: Compound IV reacts with an iodine reagent to give compound V; Compound V was reacted with a copper catalyst and a trifluoromethylating agent to give compound VI; Compound VI reacted under palladium catalyst and boriding agent conditions to give compound VII; compound VII reacted under oxidizing agent and acidic auxiliary conditions to give compound I; the synthetic route is as follows: 。 2. A method for synthesizing 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol, characterized in that, Includes the following steps: Compound II reacted with an iron catalyst, a methyl Grignard reagent, and an amide-based co-solvent to give compound III; compound III reacted with a brominating reagent to give compound IV; the synthetic route is as follows: 。 3. The method for synthesizing 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol according to claim 2, characterized in that, In the step of synthesizing compound III from compound II, the iron catalyst is ferric chloride, ferrous chloride, ferric bromide, ferrous bromide, or ferric acetylacetone; the methyl Grignard reagent is methyl magnesium chloride or methyl magnesium bromide; and the reaction solvent is tetrahydrofuran or 2-methyltetrahydrofuran.

4. The method for synthesizing 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol according to claim 2 or 3, characterized in that, In the step of synthesizing compound III from compound II, the amide co-solvent is any one of N-methylpyrrolidone, N-ethylpyrrolidone, N,N-dimethylformamide, and N,N-dimethylpropenylurea; the molar ratio of compound II: amide co-solvent: iron catalyst: methyl Grignard reagent is 1:1~2:0.01~0.05:1~3; and the reaction temperature is -60~-55℃.

5. The method for synthesizing 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol according to claim 2, characterized in that, In the step of synthesizing compound IV from compound III, the brominating agent is any one of N-bromosuccinimide, dibromohydantoin, or liquid bromine; the reaction solvent is any one of tetrahydrofuran, 2-methyltetrahydrofuran, acetonitrile, methanol, dichloromethane, or chloroform.

6. The method for synthesizing 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol according to claim 1 or 2, characterized in that, In the step of synthesizing compound V from compound IV, the iodochemical reagent is hydroiodic acid.

7. The method for synthesizing 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol according to claim 1 or 2, characterized in that, In the step of synthesizing compound VI from compound V, the copper catalyst is any one of cuprous iodide, cuprous bromide, and cuprous chloride; the trifluoromethylating agent is any one of methyl 2,2-difluoro-2-(fluorosulfonyl)acetate, trifluoromethyltrimethylsilane, and sodium trifluoromethanesulfonate; the molar ratio of compound V:copper catalyst:trifluoromethylating agent is 1:0.05~0.2:1~1.5; and the reaction temperature is 90~100℃.

8. The method for synthesizing 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol according to claim 1 or 2, characterized in that, In the step of synthesizing compound VII from compound VI, the palladium catalyst is bis(triphenylphosphine)palladium dichloride or tetra(triphenylphosphine)palladium; the borate is pinacol diborate; the base is potassium acetate; and the molar ratio of compound VI:palladium catalyst:borate:base is 1:0.02~0.1:1~3:1.5~3.

9. The method for synthesizing 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol according to claim 1 or 2, characterized in that, In the step of synthesizing compound I from compound VII, the oxidant is hydrogen peroxide; the acidic auxiliary is acetic acid.

10. A 4-methyl-2-(trifluoromethyl)pyrimidin-5-ol intermediate, characterized in that, It has the structure shown in Equation VII: 。

Citation Information

Patent Citations

  • Inhibitor compound for wnt pathway

    WO2023005894A1